SCHEMBL13074293

SCHEMBL13074293

CCC(=O)C(O)C1CCNC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.40
SLC6A4 P31645 5/20 0.40
SLC6A3 Q01959 5/20 0.40
CPN1 P15169 2/20 0.37
CPB2 Q96IY4 2/20 0.37
SLC6A1 P30531 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRB2 P47870 2/20 0.36
SLC6A12 P48065 2/20 0.36
SLC6A11 P48066 2/20 0.36
SLC6A13 Q9NSD5 2/20 0.36
GABRA1 P14867 1/20 0.36
GABRR1 P24046 1/20 0.36
GABRA4 P48169 1/20 0.36
KCNH2 Q12809 1/20 0.33
OPRD1 P41143 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA7 P36544 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9289911 0.80 CPN1 (0.37) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL22776079 0.76 CPN1 (0.46) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL6913823 0.76 CPN1 (0.34) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL16796014 0.75 KDM4E (0.39) CPN1CPB2SLC6A1GABRA5GABRB2
SCHEMBL5724460 0.74 ALDH1A1 (0.38) SLC6A2SLC6A4SLC6A3
SCHEMBL3936320 0.72
SCHEMBL12826165 0.72 SHBG (0.43)
SCHEMBL16359264 0.72 SHBG (0.43)
SCHEMBL9287656 0.72 CPN1 (0.49) CPN1CPB2SLC6A1SLC6A11SLC6A13
SCHEMBL18696400 0.72 CPN1 (0.49) CPN1CPB2SLC6A1SLC6A11SLC6A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688711-B2 Antibacterial aminoglycoside analogs ACHAOGEN, INC. (US) 2017-06-27 US disclosed
WO-2010132760-A1 ANTIBACTERIAL DERIVATIVES OF TOBRAMYCIN ACHAOGEN, INC. (US) 2010-11-18 WO disclosed